Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andreas Argyrides is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | LQDA | Buy Now | Liquidia | $12.15 | — | — | Initiates | → Perform | Get Alert |
| 06/25/2024 | MLTX | Buy Now | MoonLake | $43.97 | 136.52% | → $104 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | KROS | Buy Now | Keros Therapeutics | $45.96 | 121.93% | → $102 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | CLSD | Buy Now | Clearside Biomedical | $1.30 | 284.62% | → $5 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | GOSS | Buy Now | Gossamer Bio | $0.89 | 911.12% | → $9 | Initiates | → Outperform | Get Alert |
| 03/13/2024 | MLTX | Buy Now | MoonLake | $43.97 | 109.23% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $43.97 | 109.23% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 119.65% | → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | AQST | Buy Now | Aquestive Therapeutics | $2.58 | 248.77% | $4 → $9 | Maintains | Outperform | Get Alert |
| 03/06/2024 | GOSS | Buy Now | Gossamer Bio | $0.89 | 574.08% | → $6 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2024 | OCS | Buy Now | Oculis Holding | $12.36 | 134.63% | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | MLTX | Buy Now | MoonLake | $43.97 | 109.23% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | RGNX | Buy Now | Regenxbio | $11.50 | 82.61% | → $21 | Reiterates | Neutral → Neutral | Get Alert |
| 02/20/2024 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 41.77% | → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2024 | RGNX | Buy Now | Regenxbio | $11.50 | 82.61% | → $21 | Reiterates | Neutral → Neutral | Get Alert |
| 02/08/2024 | PCRX | Buy Now | Pacira BioSciences | $28.61 | 99.23% | → $57 | Reiterates | Outperform → Outperform | Get Alert |
| 02/08/2024 | ASND | Buy Now | Ascendis Pharma | $136.38 | 64.98% | $207 → $225 | Maintains | Outperform | Get Alert |
| 02/06/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $4.00 | 100% | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 41.77% | → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 01/09/2024 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 41.77% | → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $12.15 | -75.31% | → $3 | Reiterates | Underperform → Underperform | Get Alert |
| 12/20/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 48.12% | $200 → $202 | Maintains | Outperform | Get Alert |
| 12/19/2023 | GOSS | Buy Now | Gossamer Bio | $0.89 | 574.08% | → $6 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | MLTX | Buy Now | MoonLake | $43.97 | 109.23% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 11/21/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 41.77% | → $224 | Initiates | → Outperform | Get Alert |
| 11/17/2023 | OCS | Buy Now | Oculis Holding | $12.36 | 134.63% | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 11/16/2023 | MLTX | Buy Now | MoonLake | $43.97 | 109.23% | $86 → $92 | Maintains | Outperform | Get Alert |
| 11/16/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | — | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/13/2023 | KROS | Buy Now | Keros Therapeutics | $45.96 | 87.12% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 50.29% | $5 → $13 | Maintains | Outperform | Get Alert |
| 11/10/2023 | GOSS | Buy Now | Gossamer Bio | $0.89 | 574.08% | $5 → $6 | Maintains | Outperform | Get Alert |
| 11/08/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 40.78% | → $192 | Reiterates | Outperform → Outperform | Get Alert |
| 11/07/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/06/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/10/2023 | IMUX | Buy Now | Immunic | $1.15 | 508.7% | $5 → $7 | Maintains | Outperform | Get Alert |
| 10/10/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.58 | 55.01% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 10/10/2023 | MNKD | Buy Now | MannKind | $5.20 | 92.31% | → $10 | Initiates | → Outperform | Get Alert |
| 10/05/2023 | RGNX | Buy Now | Regenxbio | $11.50 | 73.91% | → $20 | Reiterates | Neutral → Neutral | Get Alert |
| 10/03/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 09/22/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.58 | 55.01% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 09/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | -42.2% | $15 → $5 | Maintains | Outperform | Get Alert |
| 09/18/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 40.78% | $187 → $192 | Maintains | Outperform | Get Alert |
| 08/31/2023 | KROS | Buy Now | Keros Therapeutics | $45.96 | 87.12% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/17/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $4.00 | 400% | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 73.41% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | LQDA | Buy Now | Liquidia | $12.15 | -75.31% | → $3 | Reiterates | Underperform → Underperform | Get Alert |
| 08/11/2023 | GOSS | Buy Now | Gossamer Bio | $0.89 | 461.73% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.38 | 2531.58% | $16 → $10 | Maintains | Outperform | Get Alert |
| 08/08/2023 | KROS | Buy Now | Keros Therapeutics | $45.96 | 87.12% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | -14.98% | $73 → $70 | Maintains | Neutral | Get Alert |
| 07/31/2023 | MLTX | Buy Now | MoonLake | $43.97 | 95.59% | $61 → $86 | Maintains | Outperform | Get Alert |
| 07/31/2023 | KROS | Buy Now | Keros Therapeutics | $45.96 | 87.12% | → $86 | Initiates | → Outperform | Get Alert |
| 07/27/2023 | IMUX | Buy Now | Immunic | $1.15 | 334.78% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2023 | GOSS | Buy Now | Gossamer Bio | $0.89 | 461.73% | $7 → $5 | Maintains | Outperform | Get Alert |
| 07/21/2023 | GOSS | Buy Now | Gossamer Bio | $0.89 | 686.43% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 06/30/2023 | LQDA | Buy Now | Liquidia | $12.15 | -75.31% | → $3 | Reiterates | → Underperform | Get Alert |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | -11.33% | $69 → $73 | Maintains | Neutral | Get Alert |
| 06/26/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | 51.52% | $3 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 06/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 73.41% | $17 → $15 | Maintains | Outperform | Get Alert |
| 06/07/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 37.12% | → $187 | Reiterates | Outperform → Outperform | Get Alert |
| 06/02/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 37.12% | $186 → $187 | Maintains | Outperform | Get Alert |
| 05/18/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 96.53% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 96.53% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 96.53% | → $17 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | LQDA | Buy Now | Liquidia | $12.15 | -75.31% | → $3 | Reiterates | → Underperform | Get Alert |
| 05/08/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | 36.38% | $195 → $186 | Maintains | Outperform | Get Alert |
| 04/28/2023 | OCS | Buy Now | Oculis Holding | $12.36 | 118.45% | → $27 | Initiates | → Outperform | Get Alert |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | -16.19% | $74 → $69 | Maintains | Neutral | Get Alert |
| 04/25/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | 127.27% | $5 → $3 | Maintains | Outperform | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | 278.79% | $35 → $5 | Maintains | Outperform | Get Alert |
| 03/22/2023 | MLTX | Buy Now | MoonLake | $43.97 | -24.95% | → $33 | Initiates | → Outperform | Get Alert |
| 03/20/2023 | LQDA | Buy Now | Liquidia | $12.15 | -75.31% | → $3 | Reiterates | → Underperform | Get Alert |
| 03/16/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | 2551.52% | → $35 | Reiterates | → Outperform | Get Alert |
| 03/09/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.58 | 55.01% | $3 → $4 | Upgrade | Neutral → Outperform | Get Alert |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | -10.12% | $83 → $74 | Maintains | Neutral | Get Alert |
| 02/27/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.38 | 4110.53% | → $16 | Upgrade | Neutral → Outperform | Get Alert |
| 01/31/2023 | PCRX | Buy Now | Pacira BioSciences | $28.61 | 109.72% | → $60 | Assumes | → Outperform | Get Alert |
| 01/31/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $8.65 | 15.61% | → $10 | Initiates | → Outperform | Get Alert |
| 01/31/2023 | IMUX | Buy Now | Immunic | $1.15 | 334.78% | → $5 | Assumes | → Outperform | Get Alert |
| 01/11/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 0.81% | $74 → $83 | Maintains | Neutral | Get Alert |
| 01/09/2023 | ALBO | Buy Now | Albireo Pharma | — | — | $53 → $42 | Downgrade | Outperform → Neutral | Get Alert |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $136.38 | 20.25% | $151 → $164 | Maintains | Outperform | Get Alert |
| 11/02/2022 | UBX | Buy Now | Unity Biotechnology | $1.32 | 2627.27% | $4 → $36 | Maintains | Outperform | Get Alert |
| 09/19/2022 | GOSS | Buy Now | Gossamer Bio | $0.89 | 2596.33% | → $24 | Initiates | → Outperform | Get Alert |
| 08/16/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $72 → $61 | Maintains | Outperform | Get Alert |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/13/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | -14.98% | → $70 | Assumes | → Neutral | Get Alert |
| 06/13/2022 | SGMO | Buy Now | Sangamo Therapeutics | $0.38 | 1215.79% | → $5 | Assumes | → Neutral | Get Alert |
| 06/13/2022 | RANI | Buy Now | Rani Therapeutics Hldgs | $4.00 | 600% | → $28 | Initiates | → Outperform | Get Alert |
| 12/15/2021 | RGNX | Buy Now | Regenxbio | $11.50 | 152.17% | — | Initiates | → Neutral | Get Alert |
